BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 837312)

  • 1. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella vaccination. An evolving problem for obstetrics and gynecology.
    Monif GR
    Obstet Gynecol; 1972 Feb; 39(2):304-7. PubMed ID: 5057800
    [No Abstract]   [Full Text] [Related]  

  • 5. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of rubella virus infections.
    Iwakata S; Rhodes AH; Labzoffsky NA
    Can Med Assoc J; 1973 Apr; 108(7):894-5 passim. PubMed ID: 4581796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW; Geisen HP; Kapp M; Schmidt W
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccination of young women against rubella, mainly in the post-partum period].
    Zourbas J; Toulouse R; Colombani J; Esmieu F; Buil M; Hamonou M
    Rev Fr Gynecol Obstet; 1970 Mar; 65(3):107-13. PubMed ID: 5442694
    [No Abstract]   [Full Text] [Related]  

  • 11. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
    Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
    Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rubella embryopathy, still now? (author's transl)].
    Enders G
    Geburtshilfe Frauenheilkd; 1982 May; 42(5):403-13. PubMed ID: 6921121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-rubella vaccination with Plotkin strain].
    Monnet P; Nicolas A; Lang R
    Presse Med (1893); 1970 Jan; 78(3):107-9. PubMed ID: 5418580
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years.
    Liebhaber H; Ingalls TH; Le Bouvier GL; Horstmann DM
    Am J Dis Child; 1972 Feb; 123(2):133-6. PubMed ID: 4554549
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus].
    Neumann-Haefelin D; Neumann-Haefelin Ch; Petersen EE; Luthardt Th; Hass R
    Dtsch Med Wochenschr; 1975 Jan; 100(5):177-81. PubMed ID: 1112230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.